Related by context. Frequent words. (Click for all words.) 73 transmucosal film 72 topical non steroidal 71 pseudobulbar affect PBA 70 diabetic peripheral neuropathic DPN 70 Inhalation Aerosol 69 MKC# 69 Meets Primary Endpoint 69 phenylketonuria PKU developed 68 Kuvan R 68 peripherally acting 68 gets USFDA nod 68 phenylalanine ammonia lyase 68 PEG PAL PEGylated recombinant 67 Onalta 67 Panzem R NCD 67 BEMA Buprenorphine 67 Initiates Phase II 67 AzaSite Plus 67 BEMA TM Fentanyl 67 Panzem R 67 topical anti infective 67 6R BH4 67 opioid induced bowel dysfunction 67 CDAD Clostridium difficile 67 Locteron ® 67 refractory chronic lymphocytic 67 R sorafenib tablets 66 Excellagen 66 inhaled formulation 66 sublingual tablet 66 Advancing Drugs 66 OMS#HP 66 Gabapentin GR 66 #-# rDNA origin 66 liposomal formulation 66 Ketotransdel 66 Pivotal Phase III 66 VEGFR2 inhibitor 66 Application MAA 66 Receives Orphan Drug Designation 66 Hypoactive Sexual Desire Disorder 66 injection USP 66 Staccato prochlorperazine 66 candidate Zenvia 66 KRN# 66 Release Tablets 66 VALSTAR 66 Phase Ib clinical trials 66 2 methoxyestradiol 66 Medarex applies 65 postherpetic neuralgia PHN 65 voiding dysfunctions 65 Fibrillex TM 65 Ranexa R 65 TELINTRA 65 topical gel 65 Fortical R 65 dermal patch 65 subcutaneous formulation 65 KNS # 65 huC# DM4 65 injectable formulation 65 TRANSDUR Sufentanil 65 Phase IIb clinical trials 65 ALN TTR# 65 opioid induced constipation OIC 65 Excellarate 64 Chemophase 64 monobasic monohydrate USP 64 R bortezomib 64 candidates bavituximab 64 diabetic macular edema DME 64 mesylate 64 topically delivered 64 histone deacetylase HDAC inhibitor 64 Anturol 64 fibrosis IPF 64 DAVANAT 64 Inhalation Solution 64 Romidepsin 64 cutaneous T 64 Cetrorelix 64 thymalfasin 64 Daclizumab 64 Zelrix 64 oropharyngeal candidiasis 64 Soliris TM eculizumab 64 forodesine 64 post operative ileus 64 CEQ# 64 Hematide TM 64 Proxinium TM 64 Potassium Chloride Sodium Ascorbate 64 cystic fibrosis inflammation autoimmune 64 Belimumab 64 Entereg R 63 Nanobody 63 phase IIb clinical 63 Traficet EN 63 Trofex 63 alvimopan